Code Blue Scent Elimination

Aluminum Zirconium Trichlorohydrex Gly


Vvf Kansas Services Llc
Human Otc Drug
NDC 10889-423
Code Blue Scent Elimination also known as Aluminum Zirconium Trichlorohydrex Gly is a human otc drug labeled by 'Vvf Kansas Services Llc'. National Drug Code (NDC) number for Code Blue Scent Elimination is 10889-423. This drug is available in dosage form of Stick. The names of the active, medicinal ingredients in Code Blue Scent Elimination drug includes Aluminum Zirconium Trichlorohydrex Gly - 20 g/100g . The currest status of Code Blue Scent Elimination drug is Active.

Drug Information:

Drug NDC: 10889-423
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Code Blue Scent Elimination
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Aluminum Zirconium Trichlorohydrex Gly
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Vvf Kansas Services Llc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Stick
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY - 20 g/100g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 03 Jun, 2016
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 16 Jan, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part350
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:VVF Kansas Services LLC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0707114013178
UPC stands for Universal Product Code.
UNII:T27D6T99LH
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
10889-423-0164 g in 1 APPLICATOR (10889-423-01)03 Jun, 2016N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antiperspirant

Product Elements:

Code blue scent elimination aluminum zirconium trichlorohydrex gly stearyl alcohol hydrogenated castor oil cyclomethicone 5 mineral oil silver citrate alkyl (c12-15) benzoate aluminum zirconium trichlorohydrex gly aluminum zirconium trichlorohydrex gly water talc peg-100 stearate citric acid monohydrate glyceryl stearate se

Indications and Usage:

Uses reduces underarm wetness

Warnings:

Warnings for external use only

Do Not Use:

Warnings for external use only

Dosage and Administration:

Directions apply to underarms only

Stop Use:

Stop use if rash or irritation occurs

Package Label Principal Display Panel:

Code blue labels

Further Questions:

Us/canada 1.844.282.0455 www.codebluescents.com/contact-us


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.